How the new rule impacts the travel industry

Posted by admin

By Emily Miller and David WeigelThe U.S. Food and Drug Administration (FDA) has finalized its proposed rule for regulating travel agents in the United States, the latest in a string of regulations aimed at restricting the use of foreign agents in U.K. and European markets.

The rule, which is expected to go into effect in late 2017, will be one of the biggest overhauls of the industry since the rule was announced by President Donald Trump in January.

It will prohibit companies that work with travelers to sell food, beverages, and other goods from charging them an additional fee to obtain a permit to operate in the U.U.S., the European Union, and Japan.

Travel agents are not allowed to charge for their services, and if they do, they must use third-party brokers.

They have long been exempt from the restrictions because they are exempt from some state or local regulations, such as food safety standards, in their countries of origin.

In the new rules, the FDA says travel agents can only be granted a permit if they meet the requirements of the new regulations.

Travel agents would also need to pay a fee of $25 to $50 for each day they operate in a foreign market.

But the agency says it will also allow them to operate without a permit and pay a permit fee of up to $2,000 for each individual day.

That will allow travel agents to charge up to 10 percent more than the U and E economies in each of their geographic regions, including in Europe.

That means, for example, if a trip costs $50, a U.s.-based travel agent would charge $35 for a domestic trip.

A separate rule from the Trump administration says foreign travel agents that meet the new requirements will be able to offer travel services to travelers, and can apply for a foreign license in the same way as an American travel agent.

Travelers traveling to Europe and Japan could be exempt from foreign licensing requirements in these countries, but will need to meet the existing requirements.

The new rules come at a time of heightened scrutiny over how foreign travel is handled.

It is also the second time in a year that the FDA has approved a rule that would prevent the sale of certain products to travelers from any country in the world.

In March, the agency announced that it was considering new regulations that would require companies to submit to a background check before selling certain products and services to U..

S.-based consumers.